Tacrolimus Formulation, Exposure Variability, and Outcomes in Kidney Transplant Recipients.
Elaine F LaiHuong Thao NguyenOlusegun FamureYanhong LiS Joseph KimPublished in: Progress in transplantation (Aliso Viejo, Calif.) (2022)
Under a program-wide conversion, no significant difference was observed in within-patient variability post-conversion from twice-daily to once-daily tacrolimus using the three measures of variability. High within-patient variability was associated with adverse transplant outcomes post-conversion.